Work Procedures for the Review of Drugs for Conditional Approval (Trial)

Home News Insights

Database

Laws & Regulations

Drug Catalog ChP Standards

Events

Webinars Offline Events

Services

Work Procedures for the Review of Drugs for Conditional Approval (Trial)

Local Title:药品附条件批准上市申请审评审批工作程序（试行）
Country/Region:Chinese Mainland
Competent Authority: National Medical Products Administration (NMPA)
Type:Regulation
Status:In force
Release Date:2020-07-08
Implementation Date:2020-07-08

Request

Document

Language	Source	Title	Access
ZH	Official	Work Procedures for the Review of Drugs for Conditional Approval (Trial)	Download

Summary

Conditional Approval (CA) is one of the four expedited programs for drug registration in China. The document introduces the qualification for applying for CA and the review process of the applications.